Dihydroartemisinin: Antimalarial Agent and mTOR Pathway I...
2026-04-08
Dihydroartemisinin is a research-grade antimalarial agent and mTOR signaling pathway inhibitor with validated efficacy in cell proliferation and malaria studies. Supplied by APExBIO at ≥98% purity, it offers robust reproducibility in malaria, inflammation, and cell signaling research. The compound’s defined solubility and storage requirements enable precise experimental design.
SB 203580: Dual-Action p38 MAPK Inhibitor in Signal Trans...
2026-04-08
Explore the unique dual-action mechanism of SB 203580, a selective p38 MAPK inhibitor, as it reshapes cell signaling research. Discover how this compound advances understanding in neuroprotection, multidrug resistance, and targeted kinase dephosphorylation.
BODIPY 581/591 C11: Ratiometric Fluorescent Probe for Lip...
2026-04-07
BODIPY 581/591 C11 stands out as a ratiometric fluorescent lipid peroxidation probe, enabling precise oxidative stress measurement and antioxidant capacity evaluation in live cells and model membranes. Its high specificity for lipid oxidative stress and robust photostability make it indispensable for workflows spanning cancer, neurodegenerative disease, and ferroptosis research.
Angiotensin II: Potent Vasopressor for Vascular Remodelin...
2026-04-07
Harness the full translational impact of Angiotensin II (Asp-Arg-Val-Tyr-Ile-His-Pro-Phe) in cutting-edge hypertension and cardiovascular remodeling studies. This guide delivers actionable protocols, advanced use-cases, and troubleshooting insights to ensure reproducibility and maximize scientific yield with APExBIO’s validated Angiotensin II peptide.
Zosuquidar (LY335979) 3HCl: Advanced Insights into P-gp I...
2026-04-06
Explore how Zosuquidar (LY335979) 3HCl, a potent P-glycoprotein modulator, advances multidrug resistance (MDR) reversal in cancer through integrated mechanistic, pharmacokinetic, and translational perspectives. This article uniquely examines emerging signaling pathways and clinical implications for acute myeloid leukemia and non-Hodgkin’s lymphoma.
Caspase-3 Fluorometric Assay Kit: Precision in Apoptosis ...
2026-04-06
The Caspase-3 Fluorometric Assay Kit from APExBIO delivers sensitive, rapid, and quantitative DEVD-dependent caspase activity detection, setting the standard for apoptosis and neurodegenerative disease research. Streamline your experimental workflows and troubleshoot with confidence, leveraging this kit's robust performance to accelerate mechanistic discovery and translational insight.
E-64: Irreversible L-trans-epoxysuccinyl Peptide Cysteine...
2026-04-05
E-64 is a potent, irreversible L-trans-epoxysuccinyl peptide cysteine protease inhibitor for quantitative cathepsin and calpain inhibition in biochemical and cancer research. Its nanomolar IC50, proven mechanistic specificity, and stability make it a gold-standard tool for dissecting protease signaling pathways and lysosomal cell death mechanisms.
5-Methyl-CTP: Transforming mRNA Synthesis with Next-Gener...
2026-04-04
Explore how 5-Methyl-CTP acts as a powerful modified nucleotide for in vitro transcription, uniquely enhancing mRNA stability and translation efficiency. This article uncovers advanced mechanisms, novel delivery strategies, and future applications in mRNA drug development and therapeutics.
ML385 (SKU B8300): Precision NRF2 Inhibition for Reliable...
2026-04-03
Discover how ML385 (SKU B8300), a selective NRF2 transcription factor inhibitor, addresses persistent laboratory challenges in cancer biology, oxidative stress, and ferroptosis research. With validated performance and high purity from APExBIO, this article explores real-world workflow scenarios and provides actionable insights for researchers seeking reproducible, data-driven results.
Heparin Sodium: Optimizing Anticoagulant Workflows in Thr...
2026-04-03
Heparin sodium’s unique role as a glycosaminoglycan anticoagulant makes it indispensable for advanced thrombosis research, from classic anti-factor Xa activity assays to innovative nanoparticle delivery strategies. Discover rigorous experimental workflows, key troubleshooting tips, and future-focused applications that set APExBIO’s Heparin sodium apart as a gold-standard reagent for blood coagulation pathway studies.
Cyclosporin: Benchmark Cyclophilin Inhibitor for T-cell S...
2026-04-02
Cyclosporin is a canonical immunosuppressive cyclic undecapeptide, recognized for its potent inhibition of T-cell activation and mitochondrial permeability transition pore opening. APExBIO’s Cyclosporin (SKU B8309) delivers reproducible, mechanistically validated results in immunology and mitochondrial research, supporting in vitro and in vivo workflows.
DMXAA (Vadimezan): Vascular Disrupting Agent and DT-diaph...
2026-04-02
DMXAA (Vadimezan, AS-1404) is a potent vascular disrupting agent and selective DT-diaphorase inhibitor used in cancer biology research. It induces tumor vasculature disruption, apoptosis, and autophagy in preclinical models, particularly in NSCLC cell lines. This dossier details its mechanism, benchmarks, applications, and workflow parameters for reproducible cancer research.
(1S,3R)-RSL3: GPX4 Inhibitor for Ferroptosis Induction in...
2026-04-01
(1S,3R)-RSL3 is a potent, selective glutathione peroxidase 4 (GPX4) inhibitor used as a ferroptosis inducer in cancer research. Its ability to trigger ROS-mediated, iron-dependent cell death makes it indispensable for dissecting redox vulnerabilities in RAS-driven tumors. APExBIO’s RSL3 (B6095) enables precise modulation of oxidative stress and lipid peroxidation pathways.
Itraconazole as a Translational Catalyst: Mechanistic Ins...
2026-04-01
This thought-leadership article explores the advanced mechanistic role of Itraconazole—a triazole antifungal agent and potent CYP3A4 inhibitor—in enabling translational breakthroughs against Candida biofilm resistance and antifungal drug interactions. Anchored in recent findings on autophagy-driven drug resistance, the article provides strategic guidance for researchers, highlights APExBIO’s validated Itraconazole (SKU: B2104), and offers visionary perspectives on future antifungal discovery.
Auranofin: Advanced TrxR Inhibition for Redox and Mechano...
2026-03-31
Explore the multifaceted applications of Auranofin as a thioredoxin reductase inhibitor, with a focus on redox homeostasis disruption, radiosensitization, and cytoskeleton-mediated mechanotransduction. This article uniquely integrates mechanobiology with cancer and infectious disease research for advanced scientific inquiry.
466 records 23/32 page Previous Next First page 上5页 2122232425 下5页 Last page